GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 66 or 1.1 percent, to $61.33. Hospira fell$. 84 or 1.3 percent, to $64.65.

  • Most active New York Stock Exchange-traded stocks Wednesday, 28 Jan 2015 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AK Steel Holding Corp. fell 7.8 percent to $3.92 with 26,056,200 shares traded. AT&T Inc. fell. 4 percent to $32.68 with 45,235,400 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 1:21 PM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $70.83. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $62.47. Hospira fell$. 21 or. 3 percent, to $65.28.

  • Early Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 10:41 AM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $70.93. Bristol-Myers Squibb Co. rose$. 66 or 1.1 percent, to $62.65. Hospira rose$. 30 or. 5 percent, to $65.79.

  • Final Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 6:08 PM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $70.66. Bristol-Myers Squibb Co. fell$. 47 or. 8 percent, to $61.99. Hospira fell $1.01 or 1.5 percent, to $65.49.

  • *Apple, P&G, Stryker also see headwinds. NEW YORK, Jan 27- A slew of U.S. multinational companies, from DuPont to Procter& Gamble, showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors, including industrial companies such as 3 M Co,...

  • NEW YORK, Jan 27- Pfizer Inc said on Tuesday it agreed to pay $400 million to avert a trial in a class action lawsuit accusing the pharmaceutical giant of misleading investors in connection with off-label marketing. Pfizer disclosed the agreement-in-principle as it released its fourth-quarter results. "This resolution reflects a desire by the company to...

  • *Apple also at risk; Microsoft shares plummet on currency concern. NEW YORK, Jan 27- A slew of U.S. multinational companies from DuPont to Microsoft Corp showed that a strong U.S. dollar is hammering their earnings, with several blue chip exporters predicting the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors...

  • Most active New York Stock Exchange-traded stocks Tuesday, 27 Jan 2015 | 1:36 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AK Steel Holding Corp. rose 6.4 percent to $4.31 with 11,862,600 shares traded. AT&T Inc. fell. 4 percent to $33.04 with 14,693,200 shares traded.

  • Midday Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $70.78. Bristol-Myers Squibb Co. fell$. 61 or 1.0 percent, to $61.85. Hospira fell$. 69 or 1.0 percent, to $65.81.

  • BERLIN, Jan 27- International donors pledged $7.5 billion on Tuesday to immunize 300 million children in poor countries against deadly diseases such as diarrhea and pneumonia. At a Global Alliance for Vaccines and Immunization conference in Berlin, Microsoft founder Bill Gates and the British government topped the donations list at $1.55 billion and $1.5...

  • Multinational earnings hit hard by strong dollar Tuesday, 27 Jan 2015 | 10:31 AM ET

    The impact has crossed sectors, ranging from industrials to technology, affecting companies that garner a large portion of their sales from outside the United States. United Technologies, which gets about 62 percent of its sales from outside the United States, cut its 2015 full-year outlook due to the negative impact from the stronger dollar, sending its...

  • Early Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 10:25 AM ET

    Baxter International Inc. fell$. 27 or. 4 percent, to $70.61. Bristol-Myers Squibb Co. fell$. 81 or 1.3 percent, to $61.65. Hospira fell$. 44 or. 7 percent, to $66.06.

  • Jan 27- Bristol-Myers Squibb Co on Tuesday said profits could fall as much as 16 percent in 2015, a worse forecast than Wall Street had expected, as the stronger dollar takes a toll on U.S. drugmakers. Bristol-Myers, whose shares fell almost 2 percent in premarket trading, said it earned $13 million, or 1 cent per share, in the fourth quarter. Revenue fell 4 percent to...

  • Pfizer Inc.' s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research and legal costs also reduced the bottom line. Pfizer revenues have been declining for several years amid patent expirations, which allow cheaper generic versions of its drugs to corner the market, while CEO Ian...

  • *Caterpillar shares slide as low oil prices hurt profit. *Microsoft shares tumble a day after results. NEW YORK, Jan 27- U.S. stock index futures fell on Tuesday, weighed by company earnings results including those of sector bellwethers Microsoft and Caterpillar.

  • Jan 27- Pfizer Inc reported stronger-than-expected quarterly sales due to cost cuts and demand for its vaccines and cancer drugs, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar. Excluding special items, Pfizer earned 54 cents per share. Pfizer forecast 2015 earnings of $2.00 to $2.10...

  • *Pfizer's outlook disappoints, stock slips. *Microsoft shares tumble a day after results. NEW YORK, Jan 27- U.S. stock index futures fell on Tuesday, weighed by company earnings results including those of Microsoft, while concerns lingered over Greece's new anti-bailout government and its implications for the euro zone.

  • Pfizer's 2015 forecast disappoints, hit by dollar Tuesday, 27 Jan 2015 | 7:36 AM ET

    Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.

  • Jan 27- Pfizer Inc reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar. The largest U.S. drugmaker said on Tuesday that it earned $1.23 billion, or 19 cents per share, in the fourth quarter.